Currently, kidney disease affects up to 20% of the US population and is a strong contributor to morbidity and mortality in these patients. Specific therapies and diagnostic tools for kidney disease have been very slow to develop because of the absence of high quality samples and data that can be used for research studies. The purpose of this study is to develop a registry and sample bank called Poseidon (Prevention, Optimizing Safety, Early Intervention and DetectiOn in Nephrology) biobank that can be used for future research. In this study, patients can consent to donating their residual kidney tissue if they undergo a kidney biopsy and blood or urine during routine clinical care procedures. We will also collect blood and urine outside of clinical care.This study will allow biomedical research the ability to obtain specimens from patients with relevant diseases and appropriate clinical data. This study will collect patient demographic, clinical and historical data for a registry and patient samples will be deposited in the Poseidon biobank. Patients do not have to be diagnosed with Kidney Disease to be included in this study.
Kidney failure occurring after heart failure is a serious problem leading to prolonged ICU stay, prolonged hospitalization, dialysis and death. The goal of this study is to identify patients who will develop severe kidney failure after heart surgery. Early identification of patients who will develop kidney failure after surgery will allow earlier and better treatment to prevent this complication. In this study, urine is collected after surgery and analyzed to determine the concentration of many proteins. These proteins are potential biomarkers to predict the development of kidney failure. This is a multi-center study funded by the National Institutes of Health. It is being performed at Duke University, George Washington University and the University of Tennessee. MUSC is the lead center.